Active — Not RecruitingNot Applicable

Non-interventional Study With NOVOCART® 3D for the Treatment of Cartilage Defects of the Knee in Pediatric Patients

Germany42 participantsStarted 2017-04-25

Plain-language summary

Prospective, multicenter, single-arm non-interventional study to evaluate the efficacy, safety and health economics of NOVOCART 3D in the Treatment fo cartilage defects of the knee in pediatric patients wieh closed epiphyseal growth plates.

Who can participate

Age range13 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 13 - 17 years old * Medicinal indication for NOVOCART 3D treatment Exclusion criteria: • none

What they're measuring

Change of Overall KOOS (Knee Injury and Osteoarthritis Outcome Score)

Timeframe: 24 months Follow Up (FU)

Trial details

NCT IDNCT04186208

SponsorTetec AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2023-06-14

View on ClinicalTrials.gov More Cartilage Disease trials